BARDA Begins Stockpiling APIs For Critical Drugs
Executive Summary
US agency ensures pharmaceutical companies could manufacture critical medicines domestically even if cut off from China's API suppliers, while stockpiling pandemic medicines during pandemic with Baxter, Fresenius contracts.
You may also be interested in...
Defense Secretary Asked To Brief US Congress On Pharmaceutical Supply Chain Security
Congress seeks advice from Defense Department on procuring active pharmaceutical ingredients domestically for national security purposes as efforts to identify areas of concern get underway.
Trump's Order For US Agencies To 'Buy American' Essential Medicines Has China Bracing For Impact
Many materials subject to order, APIs needed for OTC as well as Rx drugs, are supplied by companies outside the US, and China accounts for the bulk of them. The order didn't specify countries and products, leaving decisions to FDA.
China Braces As Trump Orders 'Buy American' For Essential Medicines
As the largest manufacturer of active pharmaceutical ingredients globally, China is bracing for more uncertainty amid the global pandemic and fast-changing environment, particularly in the US.